Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/11/059877
CTRI/2023/11/059877
Not yet recruiting
未知

Prevalence of Metabolic syndrome in mild Psoriasis: A Cross Sectional Study - NI

Dr Sathish Suriyaprakasam0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: L400- Psoriasis vulgaris

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: L400- Psoriasis vulgaris
Sponsor
Dr Sathish Suriyaprakasam
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Dr Sathish Suriyaprakasam

Eligibility Criteria

Inclusion Criteria

  • •Patients must be diagnosed with mild psoriasis, defined as having a body surface area (BSA) of less than 10%.
  • •Controls: Patients attending Dermatology OPD/STD OPD due to the disorders neither associated with nor prone to develop metabolic syndrome such as keloid, eczema, Sexually transmitted infections and normal patient attenders.

Exclusion Criteria

  • •Patients with psoriasis \>10% BSA
  • •Patients on phototherapy and systemic medications for psoriasis
  • •Patients with Nail psoriasis, Psoriatic arthritis
  • •Patients who are currently taking medications for any medical condition that may affect the prevalence of Metabolic syndrome.
  • •Patients with pro\-inflammatory skin conditions such as Acne, Atopic dermatitis, Alopecia, lichen planus, vitiligo, autoimmune disorders.
  • •Patients who are not willing to consent for this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Occurence of Metabolic Syndrome in patients with Heart failure
CTRI/2022/10/046656KMC, Manipal
Completed
Phase 2
PREVALENCE OF METABOLIC SYNDROME IN PSORIASIS PATIENTS AND EVALUATION OF SAFETY AND EFFICACY OF INSULIN SENSITIZERS (METFORMIN AND PIOGLITAZONE) ON METABOLIC SYNDROME IN THESE PATIENTS IN RANDOMISED OPEN LABEL PLACEBO CONTROL TRIAHealth Condition 1: null- Psoriasis with metabolic syndrome
CTRI/2011/12/002252PGIMER98
Recruiting
Not Applicable
Proportion of Metabolic Syndrome in Type II Diabetes patientsHealth Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2022/03/041435Dr Devashi Bharat Shukla
Completed
Not Applicable
Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin LevelsPsoriasis VulgarisPsoriatic ArthritisMetabolic Syndrome
NCT03932110Istanbul Medeniyet University180
Completed
Not Applicable
Physical exercise and feeding influence over obesity, high pressure, diabetes and high cholesterol in adults and elderly from Santo Antônio de Goiás city.Adult and middle aged women, overweight or obese, sedentary lifestyle, abdominal obesity, any morbidity presence such hypertension, hyperglycemia or dyslipidemias.M01.975M01.060.116M01.060.116.630C23.888.144.699C18.654.726.500F01.829.458.705C18.654.726.500.697E05.318.308.985.525C14.907.489C18.452.394.952C18.452.584.500
RBR-8rw7dzCoordenação de Aperfeiçoamento de Pessoal de Nível Superior